Veru, Inc. (VERU) Reports Q1 Loss of $0.05/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. MSFT
4. PLTR
5. META
6. JNJ
7. CSCO
8. KTOS
9. NVDA
10. QQQ

Go back to Veru, Inc. (VERU) Reports Q1 Loss of $0.05/Share

Veru Continues Strong Positive Sales Momentum in Fiscal 2020 First Quarter; Net Revenues Increase 66%, Gross Profit Up 57%

February 12, 2020 6:30 AM EST

--Completion of VERU-111 Phase 1b Clinical Trial and Initiation of Phase 2 Prostate Cancer Clinical Trial in Q2 FY 2020--

--Zuclomiphene Expected to Enter Pivotal Phase 3 Clinical Trial for Treating Hot Flashes in Men with Prostate Cancer on ADT Following Planned Meeting with FDA

--Commercial Business Continues to Deliver Robust Growth--             --Company to Host Investor Conference Call Today at 8 a.m. ET to Discuss Financial Results and Business Highlights--             

MIAMI, Feb. 12, 2020 (GLOBE... More